Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment

The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data analytics. Novartis (NYSE: NVS) stands as a driving force in this wave of transformation. From gene and cell therapies to targeted cancer treatments and immunology, Novartis consistently delivers solutions for some of the most complex health problems. CEO Vas Narasimhan goes Inside the ICE House to discuss the significant success achieved and how the company, under his leadership, sharpened its focus on innovative medicines to combat some of the world's most pressing medical challenges.

https://www.ice.com/insights/conversations/inside-the-ice-house